{{noteTA|
G1 = ME}}

{{Infobox organization
| name = 考科藍
| image = https://upload.wikimedia.org/wikipedia/en/3/3c/Cochrane_logo_stacked.svg
| image_border = 
| caption = 
| map = 
| msize = 
| mcaption = 
| abbreviation = 
| motto = 可信任實證、知情決定、更完善的健康照護
| formation = {{Start date|1993}}
| extinction = 
| type = 國際性[[非營利組織|NPO]]
| status = 
| purpose = 將有關醫療的獨立研究結果轉化為數據<!--Independent research into data about health care-->
| headquarters = [[英國|英國]][[倫敦|倫敦]] <ref name=contactingus>{{Cite web|title = Contacting us {{!}} Cochrane|url = http://community.cochrane.org/contact|website = www.cochrane.org|accessdate = 2015-09-15|deadurl = yes|archiveurl = https://web.archive.org/web/20150915025525/http://community.cochrane.org/contact|archivedate = 2015-09-15}}</ref>
| location = 
| region_served = 全球
| membership = 
| language = en
| leader_title = Steering Group Co-Chairs
| leader_name = {{le|Lisa Bero|Lisa Bero}},<br />{{le|Cindy Farquhar|Cindy Farquhar}}<ref>[http://community.cochrane.org/contact/steering-group The Cochrane Steering Group & Subgroups] {{Wayback|url=http://community.cochrane.org/contact/steering-group |date=20150921050000 }}. Retrieved 2014-02-14.</ref>
| main_organ = 
| parent_organization = 
| affiliations = 
| num_staff = 
| num_volunteers = 超過三萬七千人（2015年）<ref name=aboutus>{{Cite web|title = About us {{!}} Cochrane|url = http://www.cochrane.org/about-us|website = www.cochrane.org|accessdate = 2015-09-14}}</ref>
| budget = 
| website = {{URL|http://www.cochrane.org}}
| remarks = 
}}

'''考科藍'''（Cochrane）也稱為'''考科藍合作組織'''或'''考科藍協作組織'''，是獨立、[[非營利組織|非營利]]的[[非政府组织|非政府组织]]，由超過三萬七千名的志願者所組成，分布國家超過170個<ref name="aboutus" />。考科藍成立的目的是希望以系統化的方式組織醫學研究的資訊，依照[[實證醫學|實證醫學]]的原則來提供醫護專業人員、病人、醫療政策致訂者等人需要的資訊，以便於在醫療上的選擇<ref name=principles>{{cite web|title=Our  principles|website=Cochrane Community|url=http://www.cochrane.org/about-us/our-principles|date=January 16, 2014|publisher=Cochrane.org|accessdate=15 September 2015|archive-date=2015-01-15|archive-url=https://web.archive.org/web/20150115021717/http://www.cochrane.org/about-us/our-principles|dead-url=no}}</ref><ref>{{cite journal |author=Hill GB |title=Archie Cochrane and his legacy. An internal challenge to physicians' autonomy? |journal=J Clin Epidemiol |volume=53 |issue=12 |pages=1189–92 |date=December 2000 |pmid=11146263 |doi=10.1016/S0895-4356(00)00253-5 |url=http://linkinghub.elsevier.com/retrieve/pii/S0895-4356(00)00253-5 |access-date=2016-06-28 |archive-date=2019-06-25 |archive-url=https://web.archive.org/web/20190625205916/https://linkinghub.elsevier.com/retrieve/pii/S0895-4356(00)00253-5 |dead-url=no }}</ref>。

考科藍進行有關衛生保健介入及診斷檢查中，[[隨機對照試驗|隨機對照試驗]]的[[系統綜述|系統性文獻回顧]]，在{{le|考科藍實證醫學資料庫|Cochrane Library}}發表<ref>{{cite journal |vauthors=Scholten RJ, Clarke M, Hetherington J |title=The Cochrane Collaboration |journal=Eur J Clin Nutr |volume=59 |issue=Suppl 1 |pages=S147–9; discussion S195–6 |date=August 2005 |pmid=16052183 |doi=10.1038/sj.ejcn.1602188 |url=http://www.nature.com/ejcn/journal/v59/n1s/full/1602188a.html |access-date=2016-06-28 |archive-date=2016-03-09 |archive-url=https://web.archive.org/web/20160309204838/http://www.nature.com/ejcn/journal/v59/n1s/full/1602188a.html |dead-url=no }}</ref><ref>Ben Goldacre (2012), ''Bad Pharma'', Fourth Estate, p. 14ff.</ref>。有些綜論（例如[[職業安全|職業安全]]領域的）也會研究非随機性、[[觀察性研究|觀察性研究]]的結果<ref>{{cite journal|last1=Kongsted|first1=Hans|last2=Konnerup|first2=Merete|title=Are more observational studies being included in Cochrane Reviews?|journal=BMC Research Notes|date=2012|volume=5|issue=1|pages=570|doi=10.1186/1756-0500-5-570}}</ref>。

考科藍於2015年在臺灣設立分中心<ref>{{Cite web|title=實證醫學破迷思！考科藍台灣研究中心啟動|url=http://tw.news.yahoo.com/%E5%AF%A6%E8%AD%89%E9%86%AB%E5%AD%B8%E7%A0%B4%E8%BF%B7%E6%80%9D-%E8%80%83%E7%A7%91%E8%97%8D%E5%8F%B0%E7%81%A3%E7%A0%94%E7%A9%B6%E4%B8%AD%E5%BF%83%E5%95%9F%E5%8B%95-051606818.html|accessdate=2019-10-30|work=tw.news.yahoo.com|language=zh-TW}}</ref>。

== 歷史 ==
考科藍 (過去被稱為考科藍合作組織) 是由[[艾恩‧查默斯|艾恩‧查默斯]]爵士 (Sir Iain Geoffrey Chalmers) 帶領下於1993年成立<ref>{{Cite journal|title=Climbing a Medical Everest|url=https://science.sciencemag.org/content/300/5628/2024|last=Ault|first=Alicia|date=2003-06-27|journal=Science|issue=5628|doi=10.1126/science.300.5628.2024|volume=300|pages=2024–2025|language=en|issn=0036-8075|pmid=12829761}}</ref>。該組織是回應[[艾奇‧考科藍|艾奇‧考科藍]] (Archie Cochrane) 的呼籲而發展的，他呼籲對醫療領域中的所有相關[[隨機對照試驗|隨機對照試驗]]進行[[系統性文獻回顧|系統性文獻回顧]]，並隨時更新資訊<ref>{{Cite news|title=The Cochrane Collaboration|url=https://www.nytimes.com/2013/06/30/business/the-cochrane-collaboration.html|newspaper=The New York Times|date=2013-06-29|accessdate=2019-11-04|issn=0362-4331|language=en-US|first=Katie|last=Thomas}}</ref><ref>{{Cite journal|title=Getting to grips with Archie Cochrane's agenda.|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1883470/|last=Chalmers|first=I.|last2=Dickersin|first2=K.|date=1992-10-03|journal=BMJ : British Medical Journal|issue=6857|volume=305|pages=786–788|issn=0959-8138|pmc=1883470|pmid=1422354|last3=Chalmers|first3=T. C.}}</ref><ref>{{Cite journal|title=The Remarkable Archie: Origins of the Cochrane Collaboration|url=http://insights.ovid.com/|last=Winkelstein|first=Warren|date=2009-9|journal=Epidemiology|issue=5|doi=10.1097/EDE.0b013e3181aff391|volume=20|language=en|issn=1044-3983|pmid=19680039|access-date=2019-11-04|archive-date=2019-09-27|archive-url=https://web.archive.org/web/20190927221949/https://insights.ovid.com/|dead-url=no}}</ref>。

1998年，考科藍經濟方法學小組 (CEMG) 成立，作為推動基於[[健康經濟學|健康經濟學]]、[[循证医学|實證醫學]]與[[系統性文獻回顧|系統性文獻回顧]]的決策。

研究與發展計畫 (由[[國民保健署_(英國)|國民保健署 (英國)]]支持) 採用了考科藍的建議：方法學應該更廣泛地使用過去用於懷孕及生產中準備與維持的對照試驗<ref>{{Cite journal|title=Research and development for the National Health Service|url=http://www.sciencedirect.com/science/article/pii/014067369190494A|last=Peckham|first=Michael|date=1991-08-10|journal=The Lancet|issue=8763|doi=10.1016/0140-6736(91)90494-A|series=Originally published as Volume 2, Issue 8763|volume=338|pages=367–371|issn=0140-6736}}</ref>。透過NHS的研究與發展計畫 (由麥可‧佩卡姆為領導)，提供資金成立了「考科藍中心」，並與英國及其他地區的人合作，推動醫療各領域中[[隨機對照試驗|隨機對照試驗]]的[[系統綜述|系統性文獻回顧]]<ref>{{Cite journal|title=The Cochrane Collaboration: Evaluation of Health Care and Services Using Systematic Reviews of the Results of Randomized Controlled Trials|url=http://insights.ovid.com/|last=Dickersin|first=Kay|last2=Manheimer|first2=Eric|date=1998-6|journal=Clinical Obstetrics and Gynecology|issue=2|volume=41|pages=315–331|language=en|issn=0009-9201|pmid=9646964|access-date=2019-11-04|archive-date=2019-09-27|archive-url=https://web.archive.org/web/20190927221949/https://insights.ovid.com/|dead-url=no}}</ref>。

2004年，坎貝爾協作組織偕同CEMG 建立坎貝爾與考科藍經濟方法學小組(CCEMG)<ref>{{Cite journal|title=Economics methods in Cochrane systematic reviews of health promotion and public health related interventions|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1660547/|last=Shemilt|first=Ian|last2=Mugford|first2=Miranda|date=2006-11-15|journal=BMC Medical Research Methodology|doi=10.1186/1471-2288-6-55|volume=6|pages=55|issn=1471-2288|pmc=1660547|pmid=17107612|last3=Drummond|first3=Michael|last4=Eisenstein|first4=Eric|last5=Mallender|first5=Jacqueline|last6=McDaid|first6=David|last7=Vale|first7=Luke|last8=Walker|first8=Damian}}</ref><ref>{{Cite web|title=Welcome|url=https://methods.cochrane.org/economics/welcome|accessdate=2019-11-04|work=methods.cochrane.org|language=en}}</ref>。

2013年，該組織發表社論，描述它們在培訓開發中國家進行考科藍回顧的努力<ref>{{Cite journal|title=Cochrane and Capacity Building in Low- and Middle-Income Countries: Where are we at?|url=https://doi.org/10.1002/14651858.ED000072|last=Young|first=Taryn|last2=Garner|first2=Paul|date=2013-11-01|journal=Cochrane Database of Systematic Reviews|publisher=John Wiley & Sons, Ltd|doi=10.1002/14651858.ed000072|location=Chichester, UK|last3=Kredo|first3=Tamara|last4=Mbuagbaw|first4=Lawrence|last5=Tharyan|first5=Prathap|last6=Volmink|first6=Jimmy}}</ref>。2017年的社論簡要討論到考科藍方法學的歷史，例如使用方法學代替[[隨機對照試驗|隨機對照試驗]]及在臨床實作上使用實證資料的挑戰<ref>{{Cite journal|title=Cochrane Work—championing facts since 2003|url=https://academic.oup.com/occmed/article/67/7/504/4430930|last=Ruotsalainen|first=Jani|last2=Sauni|first2=Riitta|date=2017-10-01|journal=Occupational Medicine|issue=7|doi=10.1093/occmed/kqx073|volume=67|pages=504–506|language=en|issn=0962-7480|last3=Verbeek|first3=Jos}}</ref>。
== 標誌 ==
[[File:Pre-term_corticosteroid_data.svg|替代=]]
考科藍的標誌代表著對7個隨機對照試驗 (RCTs) 的[[統合分析|統合分析]]，它在[[森林圖|森林圖]]中比較了一種治療介入與[[安慰劑|安慰劑]]的結果。該圖顯示了給過早[[分娩|分娩]]的婦女較便宜的[[皮質類固醇|皮質類固醇]]療程的系統性文獻回顧及統合分析結果─如果在1982年就有系統性地回顧RCTs，便可以顯示證據的有效性。這項治療減少了30-50% 因為未成熟導致併發症而死亡的早產兒<ref>{{Cite journal|title=The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials|url=https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/j.1471-0528.1990.tb01711.x|last=Crowley|first=Patricia|last2=Chalmers|first2=Iain|date=1990|journal=BJOG: An International Journal of Obstetrics & Gynaecology|issue=1|doi=10.1111/j.1471-0528.1990.tb01711.x|volume=97|pages=11–25|language=en|issn=1471-0528|last3=Ke1rse|first3=Marc J. N. C.}}</ref><ref name=":0">{{Cite web|title=Our logo tells a story|url=https://www.cochrane.org/about-us/difference-we-make|accessdate=2019-11-05|author=|date=|format=|work=www.cochrane.org|publisher=|language=en}}</ref>。由於直到1990年為止，尚未發表任何關於這些試驗的系統性回顧，大部分的婦產科醫師還未意識到這種治療方式非常有效，因此當時的許多早產兒可能遭受不必要的痛苦或死亡<ref name=":0" />。

== 評論 ==
2004 年《加拿大醫學協會雜誌》的一篇社論指出，考科藍回顧似乎比其他的文獻回顧更新、品質更好，並將其描述為「方法學研究及發展後設流行病學的最佳單一資源」，並歸功於它們在領導醫學文獻方法學上的改進<ref>{{Cite journal|title=So what has the Cochrane Collaboration ever done for us? A report card on the first 10 years|url=https://www.cmaj.ca/content/171/7/747|last=Grimshaw|first=Jeremy|date=2004-09-28|journal=CMAJ|issue=7|doi=10.1503/cmaj.1041255|volume=171|pages=747–749|language=en|issn=0820-3946|pmid=15451837}}</ref>。

該研究比較考科藍與其他來源的出版研究，在[[不孕|不孕]]<ref name=":1">{{Cite journal|title=Methodological quality of systematic reviews in subfertility: a comparison of Cochrane and non-Cochrane systematic reviews in assisted reproductive technologies|url=https://academic.oup.com/humrep/article/27/12/3460/653616|last=Windsor|first=B.|last2=Popovich|first2=I.|date=2012-12-01|journal=Human Reproduction|issue=12|doi=10.1093/humrep/des342|volume=27|pages=3460–3466|language=en|issn=0268-1161|last3=Jordan|first3=V.|last4=Showell|first4=M.|last5=Shea|first5=B.|last6=Farquhar|first6=C.}}</ref>、[[物理治療|物理治療]]<ref name=":1" /><ref>{{Cite journal|title=Cochrane reviews used more rigorous methods than non-Cochrane reviews: survey of systematic reviews in physiotherapy|url=http://www.sciencedirect.com/science/article/pii/S0895435608003326|last=Moseley|first=Anne M.|last2=Elkins|first2=Mark R.|date=2009-10-01|journal=Journal of Clinical Epidemiology|issue=10|doi=10.1016/j.jclinepi.2008.09.018|volume=62|pages=1021–1030|issn=0895-4356|last3=Herbert|first3=Robert D.|last4=Maher|first4=Christopher G.|last5=Sherrington|first5=Catherine}}</ref>與[[齒顎矯正學|齒顎矯正學]]<ref>{{Cite journal|title=Cochrane and non-Cochrane systematic reviews in leading orthodontic journals: a quality paradigm?|url=https://academic.oup.com/ejo/article/35/2/244/490824|last=Fleming|first=Padhraig S.|last2=Seehra|first2=Jadbinder|date=2013-04-01|journal=European Journal of Orthodontics|issue=2|doi=10.1093/ejo/cjs016|volume=35|pages=244–248|language=en|issn=0141-5387|last3=Polychronopoulou|first3=Argy|last4=Fedorowicz|first4=Zbys|last5=Pandis|first5=Nikolaos}}</ref>領域上於統合分析的品質，結論是考科藍回顧在方法學上表現優異且嚴謹。一項更廣泛的、跨科的研究得出了相似的結論，不過這研究是由考科藍作者完成的<ref>{{Cite journal|title=Quality of Cochrane reviews: assessment of sample from 1998|url=https://www.bmj.com/content/323/7317/829|last=Olsen|first=Ole|last2=Middleton|first2=Philippa|date=2001-10-13|journal=BMJ|issue=7317|doi=10.1136/bmj.323.7317.829|volume=323|pages=829–832|language=en|issn=0959-8138|pmid=11597965|last3=Ezzo|first3=Jeanette|last4=Gøtzsche|first4=Peter C.|last5=Hadhazy|first5=Victoria|last6=Herxheimer|first6=Andrew|last7=Kleijnen|first7=Jos|last8=McIntosh|first8=Heather}}</ref>。

== 合作夥伴 ==

==== 世界衛生組織 ====
考科藍與[[世界衛生組織|世界衛生組織]]維持著正式的關係<ref>{{Cite web|title=Non-State actors in official relations with WHO|url=https://www.who.int/about/collaborations-and-partnerships/who-s-engagement-with-non-state-actors/non-state-actors-in-official-relations-with-who|accessdate=2019-11-05|work=www.who.int|language=en}}</ref>，這賦予考科藍有權任命列席代表參加WHO會議，包括[[世界衛生大會|世界衛生大會]]，並對WHO的決議發表聲明<ref>{{Cite web|title=Our funders and partners|url=https://www.cochrane.org/about-us/our-funders-and-partners|accessdate=2019-11-05|work=www.cochrane.org|language=en}}</ref>。

==== 維基百科 ====
維基百科與考科藍合作，增加納入維基百科項目的考科藍研究，並為維基百科的編輯提供解釋醫學資料的資源<ref>{{Cite journal|title=Cochrane and Wikipedia: The Collaborative Potential for a Quantum Leap in the Dissemination and Uptake of Trusted Evidence|url=https://doi.org/10.1002/14651858.ED000069|last=Mathew|first=Manu E|last2=Joseph|first2=Anna|date=2013-10-22|journal=Cochrane Database of Systematic Reviews|publisher=John Wiley & Sons, Ltd|doi=10.1002/14651858.ed000069|location=Chichester, UK|last3=Heilman|first3=James M|last4=Tharyan|first4=Prathap}}</ref>。考科藍與約翰‧威利、桑斯 (考科藍文獻回顧的出版者) 提供100個免費的考科藍帳戶給維基百科的醫學編輯，價值估計每年為3萬到8萬之間，並提供小額的補助及旅費以支援他們住在考科藍<ref>{{Cite web|title=Cochrane Collaboration Recruits Talented Wikipedian In Residence – Wikimedia Blog|url=https://blog.wikimedia.org/2014/05/05/cochrane-recruits-wikipedian-in-residence/|accessdate=2019-11-05|language=en}}</ref>。

== 公共參與 ==
考科藍有許多公眾可以參與的任務，像是製作系統性文獻回顧及其他的產出。這些任務可以被區分為「入門級」或其他更高的等級，包括：

* 加入志願者合作組織，來幫助分類與摘要醫療實證資料<ref>{{Cite web|title=Cochrane crowd|url=http://crowd.cochrane.org/index.html|accessdate=2019-11-05|work=crowd.cochrane.org|archive-date=2017-10-21|archive-url=https://web.archive.org/web/20171021003714/http://crowd.cochrane.org/index.html|dead-url=no}}</ref>
* 資料萃取與偏差的風險評估
* 將文獻回顧翻譯成其他語言

一篇最近關於人們如何參與系統性文獻回顧的系統性文獻回顧，記錄了權益關係人參與系統性文獻回顧，並利用這些資料來描述權益關係人是如何參與系統性文獻回顧<ref>{{Cite journal|title=Stakeholder involvement in systematic reviews: a scoping review|url=https://doi.org/10.1186/s13643-018-0852-0|last=Pollock|first=Alex|last2=Campbell|first2=Pauline|date=2018-11-24|journal=Systematic Reviews|issue=1|doi=10.1186/s13643-018-0852-0|volume=7|pages=208|issn=2046-4053|pmc=PMC6260873|pmid=30474560|last3=Struthers|first3=Caroline|last4=Synnot|first4=Anneliese|last5=Nunn|first5=Jack|last6=Hill|first6=Sophie|last7=Goodare|first7=Heather|last8=Morris|first8=Jacqui|last9=Watts|first9=Chris}}</ref>。有30%的病人和/或照顧者參與。

儘管存在著對考科藍是如何優先考慮系統性文獻回顧的批評<ref>{{Cite journal|title=Has Cochrane lost its way?|url=https://www.bmj.com/content/364/bmj.k5302|last=Newman|first=Melanie|date=2019-01-03|journal=BMJ|doi=10.1136/bmj.k5302|volume=364|pages=k5302|language=en|issn=0959-8138|pmid=30606713}}</ref>，但最近的一個計劃仍讓人們可以確認研究的優先次序，以提供給未來的考科藍文獻回顧<ref>{{Cite journal|title=Research priorities in health communication and participation: international survey of consumers and other stakeholders|url=https://bmjopen.bmj.com/content/8/5/e019481|last=Synnot|first=Anneliese|last2=Bragge|first2=Peter|date=2018-05-01|journal=BMJ Open|issue=5|doi=10.1136/bmjopen-2017-019481|volume=8|language=en|issn=2044-6055|pmc=PMC5942413|pmid=29739780|last3=Lowe|first3=Dianne|last4=Nunn|first4=Jack S.|last5=O’Sullivan|first5=Molly|last6=Horvat|first6=Lidia|last7=Tong|first7=Allison|last8=Kay|first8=Debra|last9=Ghersi|first9=Davina}}</ref>。

2014年，考科藍與維基百科的合作夥伴關係正式化。這支持了所有維基百科的醫學項目 (包括相關實證資料)，有助於確保維基百科中的醫學資訊具有最高的品質與精確性<ref>{{Cite web|title=The Cochrane-Wikipedia partnership in 2016|url=https://www.cochrane.org/news/cochrane-wikipedia-partnership-2016-0|accessdate=2019-11-05|work=www.cochrane.org|language=en}}</ref>。

== 參考資料 ==
{{reflist}}

== 外部連結 ==
* [http://www.cochrane.org/ Cochrane web site] {{Wayback|url=http://www.cochrane.org/ |date=20191214050721 }}

{{Authority control}}

{{實證應用}}

[[Category:系統性回顧|Category:系統性回顧]]
[[Category:實證醫學|Category:實證醫學]]
[[Category:實證應用|Category:實證應用]]
[[Category:醫療平等|Category:醫療平等]]
[[Category:国际非盈利组织|Category:国际非盈利组织]]
[[Category:健康照護品質|Category:健康照護品質]]